PPAR-γ in the Cardiovascular System
Peroxisome proliferator-activated receptor-γ (PPAR-γ), an essential transcriptional mediator of adipogenesis, lipid metabolism, insulin sensitivity, and glucose homeostasis, is increasingly recognized as a key player in inflammatory cells and in cardiovascular diseases (CVD) such as hypertension, c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2008/745804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850237427513294848 |
|---|---|
| author | Sheng Zhong Duan Christine Y. Ivashchenko Michael G. Usher Richard M. Mortensen |
| author_facet | Sheng Zhong Duan Christine Y. Ivashchenko Michael G. Usher Richard M. Mortensen |
| author_sort | Sheng Zhong Duan |
| collection | DOAJ |
| description | Peroxisome proliferator-activated receptor-γ (PPAR-γ), an essential transcriptional mediator of adipogenesis, lipid metabolism, insulin sensitivity, and glucose homeostasis, is increasingly recognized as a key player in inflammatory cells and in cardiovascular diseases (CVD) such as hypertension, cardiac hypertrophy, congestive heart failure, and atherosclerosis. PPAR-γ agonists, the thiazolidinediones (TZDs), increase insulin sensitivity, lower blood glucose, decrease circulating free fatty acids and triglycerides, lower blood pressure, reduce inflammatory markers, and reduce atherosclerosis in insulin-resistant patients and animal models. Human genetic studies on PPAR-γ have revealed that functional changes in this nuclear receptor are associated with CVD. Recent controversial clinical studies raise the question of deleterious action of PPAR-γ agonists on the cardiovascular system. These complex interactions of metabolic responsive factors and cardiovascular disease promise to be important areas of focus for the future. |
| format | Article |
| id | doaj-art-1d17facecbf545f5b1612992b11c4aa3 |
| institution | OA Journals |
| issn | 1687-4757 1687-4765 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | PPAR Research |
| spelling | doaj-art-1d17facecbf545f5b1612992b11c4aa32025-08-20T02:01:43ZengWileyPPAR Research1687-47571687-47652008-01-01200810.1155/2008/745804745804PPAR-γ in the Cardiovascular SystemSheng Zhong Duan0Christine Y. Ivashchenko1Michael G. Usher2Richard M. Mortensen3Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USAPeroxisome proliferator-activated receptor-γ (PPAR-γ), an essential transcriptional mediator of adipogenesis, lipid metabolism, insulin sensitivity, and glucose homeostasis, is increasingly recognized as a key player in inflammatory cells and in cardiovascular diseases (CVD) such as hypertension, cardiac hypertrophy, congestive heart failure, and atherosclerosis. PPAR-γ agonists, the thiazolidinediones (TZDs), increase insulin sensitivity, lower blood glucose, decrease circulating free fatty acids and triglycerides, lower blood pressure, reduce inflammatory markers, and reduce atherosclerosis in insulin-resistant patients and animal models. Human genetic studies on PPAR-γ have revealed that functional changes in this nuclear receptor are associated with CVD. Recent controversial clinical studies raise the question of deleterious action of PPAR-γ agonists on the cardiovascular system. These complex interactions of metabolic responsive factors and cardiovascular disease promise to be important areas of focus for the future.http://dx.doi.org/10.1155/2008/745804 |
| spellingShingle | Sheng Zhong Duan Christine Y. Ivashchenko Michael G. Usher Richard M. Mortensen PPAR-γ in the Cardiovascular System PPAR Research |
| title | PPAR-γ in the Cardiovascular System |
| title_full | PPAR-γ in the Cardiovascular System |
| title_fullStr | PPAR-γ in the Cardiovascular System |
| title_full_unstemmed | PPAR-γ in the Cardiovascular System |
| title_short | PPAR-γ in the Cardiovascular System |
| title_sort | ppar γ in the cardiovascular system |
| url | http://dx.doi.org/10.1155/2008/745804 |
| work_keys_str_mv | AT shengzhongduan pparginthecardiovascularsystem AT christineyivashchenko pparginthecardiovascularsystem AT michaelgusher pparginthecardiovascularsystem AT richardmmortensen pparginthecardiovascularsystem |